Trial Profile

Phase 1 Clinical trial of MAN-19 intended to treat complications caused by COVID-19

Status: Planning

Phase of Trial: Phase I

Latest Information Update: 31 Dec 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

29 Dec 2020 According to a Q BioMed media release, the Investigational New Drug (IND) application (or similar clinical trial proposal) to regulators is planned for the first quarter of 2021. This trial is planned to commencing in the first half of 2021.
26 Aug 2020 According to a Q BioMed media release, the Phase 1 clinical trial is slated to begin patient enrollment in February 2021 supported by Canadian Government
30 Jun 2020 According to a Q BioMed media release, an Investigational New Drug (IND) application (or similar clinical trial proposal) to regulators are planned for late 2020.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com